Deng, M., Zhang, M., Xu-Monette, Z. Y., Pham, L. V., Tzankov, A., Visco, C., . . . Young, K. H. (2020). XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. BMC.
Chicago Style aipamenaDeng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.
MLA aipamenaDeng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.